Evidence map›Paper›PMID 35215335›Full record

ArticlePharmaceuticals (Basel, Switzerland)2022

Influence of Semiquantitative [

Paulina Cegla, Geoffrey Currie, Joanna P Wróblewska, Witold Cholewiński, Joanna Kaźmierska, Andrzej Marszałek, Anna Kubiak, Pawel Golusinski, Wojciech Golusiński, Ewa Majchrzak

Abstract read
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Chemokine Receptor-4 Targeted PET/CT Imaging withDiagnostics (Basel, Switzerland) · 2024
    Article
  2. The transformational potential of molecular radiomics.Journal of medical radiation sciences · 2023
    Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Paulina CeglaDepartment of Nuclear Medicine, Greater Poland Cancer Center, 61-866 Poznan, Poland.ORCID 0000-0002-6676-3436
Geoffrey CurrieSchool of Dentistry and Health Science, Charles Sturt University, Wagga Wagga 2678, Australia.ORCID 0000-0002-6180-8586
Joanna P WróblewskaDepartment of Oncologic Pathology and Prophylaxis, Poznan University of Medical Sciences, 61-701 Poznan, Poland.ORCID 0000-0002-0544-321X
Witold CholewińskiDepartment of Nuclear Medicine, Greater Poland Cancer Center, 61-866 Poznan, Poland.
Joanna KaźmierskaDepartment of Electroradiology, Poznan University of Medical Science, 61-701 Poznan, Poland.
Andrzej MarszałekDepartment of Oncologic Pathology and Prophylaxis, Poznan University of Medical Sciences, 61-701 Poznan, Poland.
Anna KubiakGreater Poland Cancer Registry, Greater Poland Cancer Centre, 61-866 Poznan, Poland.ORCID 0000-0001-7363-5654
Pawel GolusinskiDepartment of Otolaryngology and Maxillofacial Surgery, University of Zielona Gora, 65-046 Zielona Góra, Poland.ORCID 0000-0002-3937-5315
Wojciech GolusińskiDepartment of Head and Neck Surgery, Poznan University of Medical Sciences, Greater Poland Cancer Center, 61-866 Poznan, Poland.
Ewa MajchrzakDepartment of Head and Neck Surgery, Poznan University of Medical Sciences, Greater Poland Cancer Center, 61-866 Poznan, Poland.

Funding

Greater Poland Cancer Centre No. 25/2019(229)
6 · The paper itself

Abstract

The aim of this study is to assess the influence of semiquantitative PET-derived parameters as well as hematological parameters in overall survival in HNSCC patients using neural network analysis. Retrospective analysis was performed on 106 previously untreated HNSCC patients. Several PET-derived parameters (SUV

Indexed as

head and neck squamous cell carcinomaneural networkoverall survivalpositron emission tomography/computed tomography

Identifiers

PMID35215335
PMCPMC8875232

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.